CEO of Atlantic Lifesciences, Dhananjay Tripathi (Right) and Executive Director of Vins Bioproducts Limited, Siddarth Daga displaying the MoU.
A memorandum of understanding (MoU) has been signed between Atlantic Lifesciences, a Ghanaian firm, and Vins Bioproducts, an Indian agency to provide anti-snake venom regionally, to avoid wasting the lives of people who find themselves bitten by snakes, generally resulting in deaths because of the lack of life-saving vaccines.
The signing of the settlement for Vins Bioproducts to produce bulk portions of anti-snake venom for the graduation of the fill and end manufacturing of the serum in Ghana, will scale back the burden on authorities to constantly import the product into the nation.
This Anti-snake venom as soon as produced by Atlantic Lifesciences can have the power to neutralise the impact of venoms from over 19 completely different species of snakes.
Due to its polyvalent nature, they are perfect for instances the place the precise kind of snake that bit a person can’t be instantly ascertained.
The native manufacturing of anti-snake venom types a part of the target of the federal government to make Ghana the hub of vaccines manufacturing in Africa.
Speaking on the signing of the MoU in Accra on Tuesday, October 18, 2023 on the National Vaccine Institute, the Presidential Advisor on Health, Dr Nsiah Asare, mentioned the manufacturing of the anti-snake venom would promote public well being within the nation.
He mentioned snake bites had been a public well being burden within the nation.
The Presidential Advisor mentioned as a part of the Vaccine Roadmap developed by the nation, the target of the federal government is to make Ghana the hub of vaccine manufacturing and export in Africa.
Dr Asare mentioned, “The production of vaccines locally is not a fluke, and the ready-to-fill anti-snake venom bulk is already in the country.”
The Chief Executive Officer of Atlantic Lifesciences, Dhananjay Tripathi, mentioned the World Health Organisation, WHO thought-about snake chew as a uncared for tropical illness that plagued rural communities.
He mentioned Pharmanova and Atlantic Lifesciences had performed essential roles in importing anti-snake venom on behalf of the federal government, and that in 2017 his outfit thought-about the transfer to begin native manufacturing of vaccines, particularly anti-snake serum.
Mr Tripathi mentioned Ghana could be the primary nation in West Africa to provide and package deal anti-snake venom for native use and export.
The Executive Director of Vins Bioproducts Limited, Siddarth Daga, mentioned his outfit was a number one producer of vaccines.
He mentioned he was excited his outfit was collaborating with Atlantic Lifesciences to provide anti-snake venom in Ghana.
Mr Daga mentioned the partnership would assist position Ghana to be the chief in vaccines manufacturing in Africa.
The Minister of Health, Mr Kwaku Agyeman Manu, in a speech learn on his behalf, mentioned the COVID-19 disrupted well being programs, ravaged economies and laid naked the vulnerabilities of nations.
He famous that Ghana couldn’t depend on imported vaccines to fulfill her well being wants.
The Minister of Health mentioned because the nation weans itself of the Global Alliance for Vaccines Initiative, you will need to produce its vaccine wants regionally.
Mr Manu mentioned it’s in that route the federal government is supporting the personal sector to provide vaccines regionally to assist promote healthcare supply.
The World Health Organization Country Representative for Ghana, Professor Francis Kasolo, in a speech learn on his behalf, mentioned on the common 9,600 snake bites had been recorded every year from 2015 to 2019.
Incidents of snakebites are an enormous downside particularly to farmers and inhabitants of the northern a part of Ghana that suffer snake bites almost every day.
“WHO is thus pleased with the signing of this MoU that signifies a joint effort to improve the availability and accessibility of safe, effective and affordable anti-snake venom, which is crucial in saving lives and reducing the mortality rate associated with snakebites,”he said.
The heads of the Food and Drugs Authority (FDA) and the Ghana Standards Authority (GSA) additionally witnessed the historic signing ceremony.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform don’t essentially symbolize the views or coverage of Multimedia Group Limited.
